AmSurg receives average “buy” rating

Eleven analyst firms have given AmSurg stock an average rating of “buy,” according to a report from The Legacy.

Advertisement
Carrie Pallardy

AmSurg stock has an average 12-month price target of $67.45. The company’s stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.

More articles on transactions and valuation issues:
4 recent orthopedics-driven ASC plans & openings
Ellis Hospital is crowdfunding its new surgery center: 4 insights
Nobilis Healthcare receives $25M loan from GE Capital

20 criteria hospital leaders should use to evaluate telepsychiatry

Recommended Whitepaper

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • The biggest ASC investments so far in 2026

    Outpatient care remains one of healthcare’s hottest investment targets in 2026. From new multimillion-dollar ASC builds to joint venture partnerships,…

    By: Cameron Cortigiano

  • Where USPI wants to win next

    Tenet’s ASC arm, United Surgical Partners International, is positioning itself for a new growth runway as Medicare begins phasing out…

    By: Patsy Newitt
Advertisement

Comments are closed.